Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Hansoh Signs $456 Million Deal for siRNA Products

Week in Review: MicroTech Medical Staging $245 Million HK IPO for Diabetes Products

Week in Review: Innovent Acquires Novel Atopic Dermatitis Treatment in $267 Million Pact

Recbio and Rhegen Form JV to Develop mRNA Vaccines including COVID

Week in Review: Broncus Stages $200 Million Hong Kong IPO for Pulmonary Devices

ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China